Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Millennium: The Takeda Oncology Company and the Worldwide Innovative Network (WIN) consortium have partnered to bring personalized anti-cancer drugs to patients.
Subscribe to our email newsletter
The WIN Consortium is a network of academic, industry, and patient advocacy organizations that works on bringing personalized cancer care to patients across the world.
WIN Consortium delegate and Millennium clinical research vice president Jesus Gomez Navarro said, "WIN’s global network of cancer centers and industry partners provides Millennium with unique opportunities to build successful industry-leading partnerships that accelerate the development of new therapies and advance our aspiration to cure cancer."
Khalifa Institute for Personalized Cancer Therapy director, The University of Texas MD Anderson Cancer Center past-president and the WIN Consortium Chairman John Mendelsohn said, "Millennium’s focus on partnership development and the development of novel oncology therapeutics for a global population strongly align with WIN’s mission and goals."